Lupus Research Alliance Announces Four New Recipients of the Lupus Mechanisms and Targets Award
Winning projects will explore new potential treatment approaches to prevent lupus from developing or prevent or slow disease progression....
Pressroom
Recent Press Releases
Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership
Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs
WASHINGTON, DC, March 29,...
Lupus Research Alliance Grants Lupus Innovation Awards to Advance Ground-Breaking Lupus Research
NEW YORK, NY, March 23, 2023. The Lupus Research Alliance (LRA) today announced the recipients of the newest Lupus...
Lupus Research Alliance Appoints New Executive Vice President of Clinical Research Affiliate Lupus Therapeutics
NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) announced the appointment of Stacie J. Bell, PhD...
Lupus Research Alliance Announces 2022 Dr. William E. Paul Distinguished Innovator Awards Investigating Harmful Immune T Cells
NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the...
Lupus Research Alliance Breaking Through Gala Raises Millions for Transformative Lupus Research
NEW YORK, NY. November 22, 2022 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala at Manhattan’s historic...
Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at...
Lupus Research Alliance Awards $9 Million to Develop Lupus Treatment Breakthroughs
NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science...
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...
Lupus Research Alliance Appoints Albert Roy as President and Chief Executive Officer
NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of...
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
Walk to Make a Difference for People with Lupus
July 25, 2022
During a time when health and wellness are top of mind, many are looking for creative ways...